Novel molecular targets for antimalarial chemotherapy

被引：60

作者：

Jana, Snehasis ^{[1
]}

Paliwal, Jyoti ^{[1
]}

机构：

[1] Ranbaxy Res Labs, Metab & Pharmacokinet Div, Gurgaon 122015, Haryana, India

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 30卷 / 01期

关键词：

drug targets; parasite transporters; parasite proteases; apicoplast; cyclin-dependent kinases;

D O I：

10.1016/j.ijantimicag.2007.01.002

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The emergence and spread of drug-resistant malaria parasites is a serious public health problem in the tropical world. Malaria control has relied upon the traditional quinoline, antifolate and artemisinin compounds. Very few new antimalarials were developed in the last quarter of the 20th century. An alarming increase in drug-resistant strains of the malaria parasite poses a significant problem for effective control. Recent advances in our knowledge of parasite biology as well as the availability of the genome sequence provide a wide range of novel targets for drug design. Gene products involved in controlling vital aspects of parasite metabolism and organelle function could be attractive targets. It is expected that the application of functional genomic tools in combination with modem approaches such as structure-based drug design and combinatorial chemistry will lead to the development of effective new drugs against drug-resistant malaria strains. This review discusses novel molecular targets of the malaria parasite available to the drug discovery scientist. (c) 2007 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

引用

页码：4 / 10

页数：7

共 46 条

[1] Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities [J].

Ancelin, ML ;

Calas, M ;

Vidal-Sailhan, V ;

Herbuté, S ;

Ringwald, P ;

Vial, HJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) :2590-2597

[2] PLASMODIUM-FALCIPARUM - DIFFERENTIAL SENSITIVITY INVITRO TO E-64 (CYSTEINE PROTEASE INHIBITOR) AND PEPSTATIN-A (ASPARTYL PROTEASE INHIBITOR) [J].

BAILLY, E ;

JAMBOU, R ;

SAVEL, J ;

JAUREGUIBERRY, G .

JOURNAL OF PROTOZOOLOGY, 1992, 39 (05) :593-599

[3] Antimalarial chemotherapy: young guns or back to the future? [J].

Biagini, GA ;

O'Neill, PM ;

Nzila, A ;

Ward, SA ;

Bray, PG .

TRENDS IN PARASITOLOGY, 2003, 19 (11) :479-487

[4]

Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461

[5] Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets [J].

Coombs, GH ;

Goldberg, DE ;

Klemba, M ;

Berry, C ;

Kay, J ;

Mottram, JC .

TRENDS IN PARASITOLOGY, 2001, 17 (11) :532-537

[6] Cyclin-dependent kinase homologues of Plasmodium falciparum [J].

Doerig, C ;

Endicott, J ;

Chakrabarti, D .

INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2002, 32 (13) :1575-1585

[7] Subcellular localization and characterization of chorismate synthase in the apicomplexan Plasmodium falciparum [J].

Fitzpatrick, T ;

Ricken, S ;

Lanzer, M ;

Amrhein, N ;

Macheroux, P ;

Kappes, B .

MOLECULAR MICROBIOLOGY, 2001, 40 (01) :65-75

[8] X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum [J].

Fritz-Wolf, K ;

Becker, A ;

Rahlfs, S ;

Harwaldt, P ;

Schirmer, RH ;

Kabsch, W ;

Becker, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :13821-13826

[9] Plasmodium parasite proteins and the infected erythrocyte [J].

Haldar, K ;

Hiller, NL ;

van Ooij, C ;

Bhattacharjee, S .

TRENDS IN PARASITOLOGY, 2005, 21 (09) :402-403

[10] 1,2-dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH) [J].

He, X ;

Reeve, AME ;

Desai, UR ;

Kellogg, GE ;

Reynolds, KA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) :3093-3102

← 1 2 3 4 5 →